3Kidney Disease: Improving Global Outcomes (KDIGO) Transplant Work Group. KDIGO Clinical practice guideline for the care of kidney transplant recipients[J ]. Am J Trans- plant, 2009, 9(3): 155.
4Fabrizi F, Takkouche B, Lunghi G, et al. The impact of hepatitis Cvires infection on survival in dialysis patients: meta -analysis of observational studies[J ]. J Viral Hepat, 2007, 14 (10): 697.
5Oyake N, Shimada T, Murakami Y, et al. Hepatitis C virus infection as a risk factor for increased aortic stiffness and car- diovascular event s in dialysis patients[J]. JNeI)hr01, 2008, 21 : 345.
6Espinosa M, Arenas M D, Aumente M D, et al. Anemia asscciated with pegylated interferon- alpha2a and alpha2b therapy in hemodialysispatients[J ]. CIin Nephrol, 2007, 67 (6) : 366.
7Chazot C,Wabel P,Chamney P,et al.Importance of normohydration for the long-term survival of haemodialysis patients[J].Nephrology Dialysis Transplantation,2012,27(6):2404-2410.
8Achinger S G,Ikizler T A,Bian A,et al.Long‐term effects of daily hemodialysis on vascular access outcomes:A prospective controlled study[J].Hemodialysis International,2013,17(2):208-215.
9Tsigalou C,Chalikias G,Kantartzi K,et al.Differential effect of baseline adiponectin on all-cause mortality in hemodialysis patients depending on initial body mass index.Longterm follow-up data of 4.5 years[J].Journal of Renal Nutrition,2013,23(1):45-56.
10German A J,Holden S L,Morris P J,et al.Long-term follow-up after weight management in obese dogs:The role of diet in preventing regain[J].The veterinary journal,2012,192(1):65-70.
